Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

CTT Pharmaceutical Holdings, Inc. CTTH OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
15/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

CTT Pharmaceutical Holdings, Inc. (CTTH) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.07. It has a SharesGrow Score of 14/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $210,000 (loss), growing at -105.5%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $16,933 against $32,183 equity (Debt-to-Equity (D/E) ratio 0.53, moderate). Current ratio is 0 (tight liquidity). Debt-to-assets is 23.2%. Total assets: $73,042.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 17/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

CTTH SharesGrow Score Overview

20/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CTTH

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
CTTH: +0%/yr revenue is, -105.5%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
17/100
Balance sheet CTTH: Debt-to-Equity (D/E) ratio 0.53 (moderate), Current ratio is 0 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
CTTH: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.017-0.1
Volume24K
Avg Volume (30D)48.8K
Market Cap$1.49M
Beta (1Y)0.57
Share Statistics
EPS (TTM)0.00
Shares Outstanding$52.4M
IPO Date1997-04-21
Employees2
CEORyan Khouri
Financial Highlights & Ratios
EBITDA$-207K
Net Income$-210K
Operating Income$-250K
Total Cash$114.00
Total Debt$16.93K
Net Debt$16.82K
Total Assets$73.04K
Price / Earnings (P/E)-17.9
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINUS12651E1064

Price Chart

Track all markets on TradingView
CTTH
CTT Pharmaceutical Holdings, Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.02 52WK RANGE 0.10

People Also View

RDDTF
RDDTF
Radient Technologies Inc.
$0.00
+0.00%
 CHOOF
CHOOF
Choom Holdings Inc.
$0.00
+0.00%
 MRRCF
MRRCF
Wayland Group Corp.
$0.00
+0.00%
 BLEVF
BLEVF
Beleave Inc.
$0.00
+9,999.00%
 SNNVF
SNNVF
Sunniva Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message